课题基金 / 基金详情

Myofibroblasts, T cells and malignant cells interplay in breast cancer metastasis

Myofibroblasts, T cells and malignant cells interplay in breast cancer metastasis
肌成纤维细胞、T 细胞和恶性细胞在乳腺癌转移中相互作用
批准号:
8523028
负责人:
Weizhou Zhang
金额:
$23.06万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-07-01 至 2015-06-30

项目摘要

项目成果

Weizhou Zhang的其他基金

相关文献

中文摘要
翻译
项目总结
英文摘要
Project Summary The general goal of the proposed research is to understand how cancer associated stroma, including cancer associated fibroblast (CAF), tumor infiltrating lymphocytes (TIL) and their interactions with carcinoma cells contributes to pulmonary metastasis of breast cancer. CAF and TIL are critically involved in mammary tumorigenesis and metastasis. To address the role of CAF and TIL in pulmonary metastasis of mammary cancer, we have established several spontaneous and transplant mammary tumor models. Our research demonstrates that receptor for activated nuclear factor ¿B ligand (RANKL) is expressed by tumor infiltrating CD4+ T cells, mainly Treg cells in tumor associated stroma. RANKL activates its cognate receptor RANK on cell surface of carcinoma cells, which leads to the activation and nuclear translocation of IKK¿ and in turn the repression of maspin, a key metastasis inhibitor in a variety of cancers. However, the links between carcinoma cells, CAF, and CD4+CD25+ T cells still remain obscure. I therefore propose to pursue the following aims: Identify other factors from CAFs responsible for Treg cell infiltration into tumor; Identify signaling pathway that controls chemokine expression from CAF; Examine the role of carcinoma cells in fibroblast activation; Examine the role of alternative NF-¿B pathways components, including NF-¿B inducing kinase (NIK), TRAF2, and TRAF3 in ErbB2-induced mammary tumor development and metastasis; and identify upstream members, if other than RANKL that activates NIK/IKK¿ during mammary tumorigenesis. The proposed studies are innovative as they address a poorly explored and controversial research problem with great clinical significance and public health importance.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Exploring novel therapeutic strategies for combinatory therapy to treat renal clear cell carcinomas
  • 批准号:
    10608244
  • 项目类别:
  • 资助金额:
    $50.52万
  • 财政年份:
    2023
  • 负责人:
    Weizhou Zhang
  • 依托单位:
CD177 suppresses breast-cancer development by inhibiting beta-catenin
  • 批准号:
    10004577
  • 项目类别:
  • 资助金额:
    $34.2万
  • 财政年份:
    2016
  • 负责人:
    Weizhou Zhang
  • 依托单位:
Obesity, inflammation and breast cancer
  • 批准号:
    9003551
  • 项目类别:
  • 资助金额:
    $34.58万
  • 财政年份:
    2015
  • 负责人:
    Weizhou Zhang
  • 依托单位:
Myofibroblasts, T cells and malignant cells interplay in breast cancer metastasis
  • 批准号:
    8481645
  • 项目类别:
  • 资助金额:
    $24.9万
  • 财政年份:
    2012
  • 负责人:
    Weizhou Zhang
  • 依托单位: